bioMérieux (EPA: BIM) revenue
bioMérieux reported revenue of €4,070m for fiscal 2025, 2.3% more than in fiscal 2024 (€3,980m). Since fiscal 2019 its revenue has grown by 52.2%, an average growth of 7.2% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | €4,070m | +2.3% | €521.3m | 12.8% |
| 2024 | €3,980m | +8.3% | €588.8m | 14.8% |
| 2023 | €3,675m | +2.4% | €439.0m | 11.9% |
| 2022 | €3,589m | +6.3% | €587.2m | 16.4% |
| 2021 | €3,376m | +8.3% | €784.3m | 23.2% |
| 2020 | €3,118m | +16.6% | €552.8m | 17.7% |
| 2019 | €2,675m | — | €370.7m | 13.9% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of euros, except per-share amounts.
Questions about the revenue of bioMérieux
- How much revenue did bioMérieux make in fiscal 2025?
- bioMérieux reported revenue of €4,070m for fiscal 2025, compared with €3,980m in fiscal 2024.
- How much has the revenue of bioMérieux grown?
- Between fiscal 2019 and fiscal 2025 it went from €2,675m to €4,070m: 52.2% more, an average growth of 7.2% a year.
- What was the best year for revenue at bioMérieux?
- Of its last 7 fiscal years, fiscal 2025, with €4,070m.
- Where do the figures for bioMérieux come from?
- From the report bioMérieux files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
From the annual report bioMérieux files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on bioMérieux: the bioMérieux page · annual accounts · net income.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.